111 related articles for article (PubMed ID: 15127886)
1. Cyclin-dependent kinase inhibitor, p21Waf1, regulates vascular smooth muscle cell hypertrophy.
Okamoto K; Kato S; Arima N; Fujii T; Morimatsu M; Imaizumi T
Hypertens Res; 2004 Apr; 27(4):283-91. PubMed ID: 15127886
[TBL] [Abstract][Full Text] [Related]
2. [The role of cyclin-dependent kinase inhibitors in hyperplasia and hypertrophy of vascular smooth muscle cells].
Xu D; Wang M; Liu Y
Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(11):680-3. PubMed ID: 11798949
[TBL] [Abstract][Full Text] [Related]
3. Cell cycle inhibitors (p27Kip1 and p21CIP1) cause hypertrophy in LLC-PK1 cells.
Terada Y; Inoshita S; Nakashima O; Tamamori M; Ito H; Kuwahara M; Sasaki S; Marumo F
Kidney Int; 1999 Aug; 56(2):494-501. PubMed ID: 10432388
[TBL] [Abstract][Full Text] [Related]
4. A novel role for the cyclin-dependent kinase inhibitor p27(Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy.
Braun-Dullaeus RC; Mann MJ; Ziegler A; von der Leyen HE; Dzau VJ
J Clin Invest; 1999 Sep; 104(6):815-23. PubMed ID: 10491417
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of p27kip1 levels and CDK activities by hypertrophic and hyperplastic agents in vascular smooth muscle cells.
Rao GN
Biochim Biophys Acta; 1999 Jan; 1448(3):525-32. PubMed ID: 9990305
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of mutated IkappaBalpha inhibits vascular smooth muscle cell proliferation and intimal hyperplasia formation.
Zuckerbraun BS; McCloskey CA; Mahidhara RS; Kim PK; Taylor BS; Tzeng E
J Vasc Surg; 2003 Oct; 38(4):812-9. PubMed ID: 14560235
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of vascular smooth muscle cell proliferation by sodium salicylate mediated by upregulation of p21(Waf1) and p27(Kip1).
Marra DE; Simoncini T; Liao JK
Circulation; 2000 Oct; 102(17):2124-30. PubMed ID: 11044431
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of p21Waf-1 in vascular smooth muscle cells: regulation of proliferation, differentiation, and cell size.
Kato S; Yamaguchi M; Fujii T; Miyagi N; Terasaki M; Hamada T; Sugita Y
Exp Mol Pathol; 1999 Apr; 66(1):39-52. PubMed ID: 10331963
[TBL] [Abstract][Full Text] [Related]
9. [Regulation of cyclin-dependent kinase inhibitors by mitogen-activated protein kinase in angiotensin II-stimulated vascular smooth muscle cell hypertrophy].
Liu Y; Xu DL; Wang MH; Ouyang P; Lai WY
Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):114-6. PubMed ID: 12390801
[TBL] [Abstract][Full Text] [Related]
10. eNOS gene transfer to vascular smooth muscle cells inhibits cell proliferation via upregulation of p27 and p21 and not apoptosis.
Sato J; Nair K; Hiddinga J; Eberhardt NL; Fitzpatrick LA; Katusic ZS; O'Brien T
Cardiovasc Res; 2000 Sep; 47(4):697-706. PubMed ID: 10974218
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of p21Waf1 induces apoptosis in immortalized human vascular smooth muscle cells.
Kato S; Ueda S; Yamaguchi M; Miyamoto T; Fujii T; Izumaru S; Kume S; Toyozumi Y; Arima N; Morimatsu M
J Atheroscler Thromb; 2003; 10(4):239-45. PubMed ID: 14566087
[TBL] [Abstract][Full Text] [Related]
12. Tranilast inhibits vascular smooth muscle cell growth and intimal hyperplasia by induction of p21(waf1/cip1/sdi1) and p53.
Takahashi A; Taniguchi T; Ishikawa Y; Yokoyama M
Circ Res; 1999 Mar; 84(5):543-50. PubMed ID: 10082476
[TBL] [Abstract][Full Text] [Related]
13. Cyclin A downregulation and p21(cip1) upregulation correlate with GATA-6-induced growth arrest in glomerular mesangial cells.
Nagata D; Suzuki E; Nishimatsu H; Yoshizumi M; Mano T; Walsh K; Sata M; Kakoki M; Goto A; Omata M; Hirata Y
Circ Res; 2000 Oct; 87(8):699-704. PubMed ID: 11029406
[TBL] [Abstract][Full Text] [Related]
14. p27(Kip1) is important in modulating pulmonary artery smooth muscle cell proliferation.
Fouty BW; Grimison B; Fagan KA; Le Cras TD; Harral JW; Hoedt-Miller M; Sclafani RA; Rodman DM
Am J Respir Cell Mol Biol; 2001 Nov; 25(5):652-8. PubMed ID: 11713109
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism of progesterone-induced antiproliferation in rat aortic smooth muscle cells.
Lee WS; Liu CW; Juan SH; Liang YC; Ho PY; Lee YH
Endocrinology; 2003 Jul; 144(7):2785-90. PubMed ID: 12810531
[TBL] [Abstract][Full Text] [Related]
16. Effects of an angiotensin II receptor antagonist, CV-11974, on angiotensin II-induced increases in cytosolic free calcium concentration, hyperplasia, and hypertrophy of cultured vascular smooth muscle cells.
Koh E; Morimoto S; Tomita J; Rakugi H; Jiang B; Inoue T; Nabata T; Fukuo K; Ogihara T
J Cardiovasc Pharmacol; 1994 Feb; 23(2):175-9. PubMed ID: 7511744
[TBL] [Abstract][Full Text] [Related]
17. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
Touyz RM; Yao G
J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
[TBL] [Abstract][Full Text] [Related]
18. TZDs inhibit vascular smooth muscle cell growth independently of the cyclin kinase inhibitors p21 and p27.
Hupfeld CJ; Weiss RH
Am J Physiol Endocrinol Metab; 2001 Aug; 281(2):E207-16. PubMed ID: 11440895
[TBL] [Abstract][Full Text] [Related]
19. [Expression of cyclin dependent kinase inhibitor p27 during proliferation in vascular smooth muscle cell].
Yuan Y; Xu DL; Liu YL; Jia MY
Sheng Li Xue Bao; 1999 Jun; 51(3):285-90. PubMed ID: 11498990
[TBL] [Abstract][Full Text] [Related]
20. Honokiol causes the p21WAF1-mediated G(1)-phase arrest of the cell cycle through inducing p38 mitogen activated protein kinase in vascular smooth muscle cells.
Lee B; Kim CH; Moon SK
FEBS Lett; 2006 Oct; 580(22):5177-84. PubMed ID: 16962592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
